Paul Matheis

RITE AID PHARMACY #1292

270 MAIN ST

Articles

Xcovery set to begin Phase I/II AMD trial with oral drug candidate

Xcovery Holdings starts Phase I/II trials of oral angiogenesis inhibitor, X-82, for neovascular wet age-related macular degeneration (AMD).

PBA Supports National Falls Prevention Awareness Day

People with vision impairments are more than twice as likely to fall. So Prevent Blindness America (PBA) supports National Falls Prevention Day on the 22nd.